🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To determine whether amcenestrant per overall survival ...
Status
Terminated
Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Start Date
2019-10-22
Trial ID
NCT04059484
Treatments Being Tested
Primary Objective: To assess the incidence rate of dose-limiting toxicity ...
Status
Terminated
Location
Investigational Site Number : 3920003
Start Date
2019-03-25
Trial ID
NCT03816839
Treatments Being Tested
This was a phase III, randomized, double blind, multicenter, 2-arm study ev...
Status
Terminated
Location
Investigational Site Number :1521622
Start Date
2022-02-17
Trial ID
NCT05128773
Treatments Being Tested
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
Primary Objective: To determine whether Amcenestrant (SAR439859) in combin...
Status
Terminated
Location
Investigational Site Number :8400075
Start Date
2020-10-14
Trial ID
NCT04478266
Primary Objective: To determine whether amcenestrant given at 2 different ...
Status
Terminated
Location
Investigational Site Number 8400014
Start Date
2020-02-04
Trial ID
NCT04191382
Treatments Being Tested
Primary Objectives: * To assess the excretion balance after oral and IV ad...
Status
Completed
Location
Investigational Site Number 8260001
Start Date
2021-06-15
Trial ID
NCT04940026
Treatments Being Tested
Primary Objectives: Dose Escalation: * To assess the incidence rate of do...
Status
Terminated
Location
University of Colorado - Anschutz Medical Campus- Site Number : 8400005
Start Date
2017-09-20
Trial ID
NCT03284957
Treatments Being Tested